Thomas Braxton King

Thomas Braxton King has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Achieve Life Sciences, Inc. and TFF Pharmaceuticals, Inc. Over a trading history stretching from 3 July 2024 to 4 September 2025, the count stands at 2 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 8 September 2025, reports an option exercise in Achieve Life Sciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.